EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.30−0.01 (-3.80%)
Close on Nov 17, 2026Market cap $25.51MP/E –Yield –
EyePoint price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
EyePoint's price to sales ratio was 10.9× on Nov 11, 2026, against 24.4× a year earlier. Over the last 5 years it ranged from 2.4× to 156.7×, with a median of 10.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.9× | −19.2 |
| 2025 | Dec 31, 2025 | 30.0× | +21.3 |
| 2024 | Dec 31, 2024 | 8.7× | −10.5 |
| 2023 | Dec 29, 2023 | 19.2× | +16.4 |
| 2022 | Dec 30, 2022 | 2.8× | −8.0 |
| 2021 | Dec 31, 2021 | 10.8× | −18.4 |
| 2020 | Dec 31, 2020 | 29.2× | −9.8 |
| 2019 | Dec 31, 2019 | 39.0× | −8.6 |
| 2018 | Dec 31, 2018 | 47.6× | +41.9 |
| 2017 | Dec 29, 2017 | 5.7× | −35.2 |
| 2016 | Dec 30, 2016 | 40.8× | −41.4 |
| 2015 | Dec 31, 2015 | 82.2× | +78.0 |
| 2014 | Dec 31, 2014 | 4.3× | −44.4 |
| 2013 | Dec 31, 2013 | 48.6× | +37.0 |
| 2012 | Dec 31, 2012 | 11.6× | +7.9 |
| 2011 | Dec 30, 2011 | 3.8× | −0.4 |
| 2010 | Dec 31, 2010 | 4.2× | – |
See a number that looks wrong?